Daewon Pharmaceutical Co., Ltd. (KRX:003220)
13,040
-10 (-0.08%)
At close: Oct 24, 2025
Daewon Pharmaceutical Market Cap
Daewon Pharmaceutical has a market cap or net worth of 279.49 billion as of October 24, 2025. Its market cap has decreased by -12.83% in one year.
Market Cap
279.49B
Enterprise Value
425.96B
Revenue
603.74B
Ranking
n/a
PE Ratio
30.51
Stock Price
13,040.00
Market Cap Chart
Since March 1, 2001, Daewon Pharmaceutical's market cap has increased from 18.06B to 279.49B, an increase of 1,447.58%. That is a compound annual growth rate of 11.75%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 24, 2025 | 279.49B | -8.49% |
| Dec 30, 2024 | 305.43B | -7.98% |
| Dec 28, 2023 | 331.93B | -15.58% |
| Dec 29, 2022 | 393.20B | 14.64% |
| Dec 30, 2021 | 343.00B | -9.91% |
| Dec 30, 2020 | 380.71B | 13.65% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 83.84T |
| Celltrion | 38.09T |
| ALTEOGEN | 23.85T |
| Yuhan | 8.54T |
| SK Biopharmaceuticals | 8.34T |
| Peptron | 6.00T |
| HLB Co., Ltd. | 5.98T |
| PharmaResearch | 5.69T |